Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity.
Hulgan
Todd
T
Haas
David W
DW
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D019380:Anti-HIV Agents / Q000009:adverse effects*; D005198:Fanconi Syndrome / Q000139:chemically induced* / Q000235:genetics; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006239:Haplotypes; D006801:Humans; D026901:Membrane Transport Proteins / Q000235:genetics*; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins / Q000235:genetics*; D063065:Organophosphonates / Q000009:adverse effects*; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D000068698:Tenofovir
D000225:Adenine; D019380:Anti-HIV Agents; D026901:Membrane Transport Proteins; D000089762:Multidrug Resistance-Associated Protein 2; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D063065:Organophosphonates; D000068698:Tenofovir